7 Works

Supplementary Figure S1. Novel protein markers of androgen activity in humans with potential clinical value

Aleksander Giwercman, K. Barbara Sahlin, Indira Pla, Krzysztof Pawlowski, Yvonne Lundberg Giwercman, Irene Leijonhufvud, Roger Appelqvist, Aniel Sanchez & Johan Malm
Supplementary Figure S1. Boxplots based on the Log2 intensities of the differentially expressed proteins (Table S5). The healthy human model (i.e. castrated men).

Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer

Anders Ekström, Eva Brun, Jakob Eberhard & Mikael Segerlantz
Pancreatic cancer is a highly lethal disease with a close association between incidence and mortality. First-line (FL) palliative chemotherapy prolongs survival and alleviates cancer-related symptoms. However, the survival benefit of second-line (SL) treatment is uncertain, as studies fail to consistently show prolonged survival for any given SL treatment, and in the absence of prognostic factors patients will receive a futile treatment. The aim of this study was to examine prognostic factors and survival in patients...

A possible association between early life factors and burden of functional bowel symptoms in adulthood

Johanna Wennerberg, Shantanu Sharma, Peter M. Nilsson & Bodil Ohlsson
The studies of early life factors and development of functional bowel diseases show inconsistent results. We therefore examined associations between certain early life factors and functional bowel symptoms in adulthood. Population-based cross-sectional study. Weight and height were measured and questionnaires were completed at the time point of enrollment in MOS. 1013 participants in the Malmö Offspring Study (MOS) without organic bowel disease with data available from the Swedish Medical Birth Registry. Associations were calculated between...

A possible association between early life factors and burden of functional bowel symptoms in adulthood

Johanna Wennerberg, Shantanu Sharma, Peter M. Nilsson & Bodil Ohlsson
The studies of early life factors and development of functional bowel diseases show inconsistent results. We therefore examined associations between certain early life factors and functional bowel symptoms in adulthood. Population-based cross-sectional study. Weight and height were measured and questionnaires were completed at the time point of enrollment in MOS. 1013 participants in the Malmö Offspring Study (MOS) without organic bowel disease with data available from the Swedish Medical Birth Registry. Associations were calculated between...

Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer

Anders Ekström, Eva Brun, Jakob Eberhard & Mikael Segerlantz
Pancreatic cancer is a highly lethal disease with a close association between incidence and mortality. First-line (FL) palliative chemotherapy prolongs survival and alleviates cancer-related symptoms. However, the survival benefit of second-line (SL) treatment is uncertain, as studies fail to consistently show prolonged survival for any given SL treatment, and in the absence of prognostic factors patients will receive a futile treatment. The aim of this study was to examine prognostic factors and survival in patients...

Diagnostic performance of left ventricular mechanical dyssynchrony indices using CMR feature tracking

Daniel Loewenstein, Björn Wieslander, Einar Heiberg, Jimmy Axelsson, Igor Klem, Robin Nijveldt, Erik B Schelbert, Peder Sörensson, Andreas Sigfridsson, David G. Strauss, Raymond Kim, Brett Atwater & Martin Ugander
This dataset has been curated and made available as part of a study by Loewenstein, et al (https://doi.org/10.1101/2022.11.11.22282225). The aim of the study was to evaluate the diagnostic performance of mechanical dyssynchrony indices in a study population of patients with severely reduced ejection fraction and no LV myocardial scar assessed by cardiovascular magnetic resonance (CMR), and either left bundle branch block (LBBB) or normal QRS duration.
We retrospectively identified 80 patients from three centers,...

Supplementary Figure S1. Novel protein markers of androgen activity in humans with potential clinical value

Aleksander Giwercman, K. Barbara Sahlin, Indira Pla, Krzysztof Pawlowski, Yvonne Lundberg Giwercman, Irene Leijonhufvud, Roger Appelqvist, Aniel Sanchez & Johan Malm
Supplementary Figure S1. Boxplots based on the Log2 intensities of the differentially expressed proteins (Table S5). The healthy human model (i.e. castrated men).

Registration Year

  • 2021
    7

Resource Types

  • Text
    4
  • Image
    2
  • Dataset
    1

Affiliations

  • Lund University
    7
  • Skåne University Hospital
    7
  • Wildlife Institute of India
    2
  • California Institute of Technology
    2